AJP - Endo AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 291: E73-E79, 2006. First published January 24, 2006; doi:10.1152/ajpendo.00287.2005
0193-1849/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
291/1/E73    most recent
00287.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reid, M.
Right arrow Articles by Jahoor, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reid, M.
Right arrow Articles by Jahoor, F.

In vivo rates of erythrocyte glutathione synthesis in adults with sickle cell disease

Marvin Reid,1 Asha Badaloo,2 Terrence Forrester,2 and Farook Jahoor3

1Sickle Cell Unit and 2Tropical Metabolism Research Unit, Tropical Medicine Research Institute, University of the West Indies, Mona, Kingston, Jamaica; and 3United States Department of Agriculture/Agricultural Research Service, Children’s Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, Texas

Submitted 24 June 2005 ; accepted in final form 21 January 2006

Despite reports of lower GSH concentration in sickle cell disease (SCD), the in vivo kinetic mechanism(s) responsible for GSH deficiency is unknown. To determine whether suppressed synthesis was responsible for the lower erythrocyte GSH concentration, we used a primed intermittent infusion of [2H2]glycine to measure erythrocyte GSH synthesis in vivo in 23 individuals with homozygous betas SCD and 8 healthy controls. Erythrocyte cysteine concentration, the rate-limiting precursor for GSH synthesis, plasma markers of oxidant damage, and dietary intakes of energy and protein were also measured. Compared with values of controls, SCD subjects had significantly lower erythrocyte GSH (P < 0.04) and cysteine concentrations (P < 0.004) but significantly faster fractional rates of GSH synthesis (P < 0.02). The absolute rates of GSH synthesis in SCD subjects compared with control subjects was greater by ~57% (P = 0.062). However, the concentrations of markers of oxidative damage, plasma derivatives of reactive oxygen metabolites, plasma nitrotyrosine, urinary isoprostane-to-creatinine ratio, and GSH-to-GSSG ratio, as well as dietary intakes of energy, protein, and GSH precursor amino acids, were not different between SCD subjects and controls. The findings of this study suggest that the lower erythrocyte GSH of SCD patients is not due to suppressed synthesis or impaired regeneration but rather to increased consumption. In addition, the lower erythrocyte cysteine concentration plus the faster rate of GSH synthesis strongly suggest that the endogenous cysteine supply is not sufficient to meet all anabolic demands; hence, cysteine may be a conditionally essential amino acid in individuals with SCD.

cysteine; oxidative stress; antioxidant capacity



Address for reprint requests and other correspondence: M. Reid, Sickle Cell Unit, Tropical Medicine Research Institute, Univ. of the West Indies, Mona, Kingston 7, Jamaica (e-mail: marvin.reid{at}uwimona.edu.jm)




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
Y. Lamers, B. O'Rourke, L. R Gilbert, C. Keeling, D. E Matthews, P. W Stacpoole, and J. F Gregory III
Vitamin B-6 restriction tends to reduce the red blood cell glutathione synthesis rate without affecting red blood cell or plasma glutathione concentrations in healthy men and women
Am. J. Clinical Nutrition, August 1, 2009; 90(2): 336 - 343.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
G. Courtney-Martin, M. Rafii, L. J. Wykes, R. O. Ball, and P. B. Pencharz
Methionine-Adequate Cysteine-Free Diet Does Not Limit Erythrocyte Glutathione Synthesis in Young Healthy Adult Men
J. Nutr., November 1, 2008; 138(11): 2172 - 2178.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
D. R. Archer, J. K. Stiles, G. W. Newman, A. Quarshie, L. L. Hsu, P. Sayavongsa, J. Perry, E. M. Jackson, and J. M. Hibbert
C-Reactive Protein and Interleukin-6 Are Decreased in Transgenic Sickle Cell Mice Fed a High Protein Diet
J. Nutr., June 1, 2008; 138(6): 1148 - 1152.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
C. R. Morris
Mechanisms of Vasculopathy in Sickle Cell Disease and Thalassemia
Hematology, January 1, 2008; 2008(1): 177 - 185.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. R. Morris, J. H. Suh, W. Hagar, S. Larkin, D. A. Bland, M. H. Steinberg, E. P. Vichinsky, M. Shigenaga, B. Ames, F. A. Kuypers, et al.
Erythrocyte glutamine depletion, altered redox environment, and pulmonary hypertension in sickle cell disease
Blood, January 1, 2008; 111(1): 402 - 410.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
J. Thompson, M. Reid, I. Hambleton, and G. R. Serjeant
Albuminuria and Renal Function in Homozygous Sickle Cell Disease: Observations From a Cohort Study
Arch Intern Med, April 9, 2007; 167(7): 701 - 708.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.